Phox2B is a transcription factor responsible for chromaffin cell phenotype. Although it is used routinely for diagnosis of neuroblastoma, previous reports concerning its utility in the diagnosis of neuroendocrine neoplasms have been conflicting. We assessed Phox2b immunoreactivity in different neuroendocrine neoplasms. Tissue microarrays or whole sections of 36 paragangliomas (PGs), 91 well-differentiated neuroendocrine tumours of different organs (WDNETs), 31 neuroendocrine carcinomas (NECs), and 6 olfactory neuroblastomas (ONBs) were stained with Phox2B antibody (EP312) and GATA3. The percentage of positive cells and intensity was analysed using H-score. Phox2B immunoreactivity was seen in 97.2% (35/36) PGs, 11% (10/91) WDNETs, 9.7% (3/31) NECs, and 16.7% (1/6) ONBs. PGs were significantly more often positive (p < 0.001, χ2) than other neuroendocrine tumours, showing highest H-score (mean 144.9, SD ± 75.1) and percentage of positive cells (median 81.3%, IQR 62.5-92.5%). Compared to Phox2B-positive WDNETs, PGs showed significantly higher H-score (median 145 vs 7.5, p < 0.001) and percentage of positive cells (median 82.5% vs 4.5%, p < 0.001). Phox2B positivity was 97.2% sensitive and 89% specific for the diagnosis of PG. GATA3 was 100% sensitive and 88% specific for the diagnosis of PG. When combined, any Phox2B/GATA3 coexpression was 97.1% sensitive and 99.1% specific for the diagnosis of paraganglioma. Widespread Phox2B immunoreactivity is a highly characteristic feature of PGs and it can be used as an additional marker in differential diagnosis of neuroendocrine tumours.

4th Department of Internal Medicine Charles University Faculty of Medicine in Hradec Králové and University Hospital Hradec Králové Hradec Králové Czech Republic

Department of Pathology The Regional Hospital Pardubice Pardubice Czech Republic

The Fingerland Department of Pathology Charles University Faculty of Medicine in Hradec Králové and University Hospital Hradec Králové Sokolska 581 500 05 Hradec Králové Czech Republic

See more in PubMed

Asa SL, Mete O (2021) Cytokeratin profiles in pituitary neuroendocrine tumors. Hum Pathol 107:87–95. https://doi.org/10.1016/j.humpath.2020.10.004 PubMed DOI

Beumer J, Puschhof J, Bauza-Martinez J, Martinez-Silgado A, Elmentaite R, James KR, Ross A, Hendriks D, Artegiani B, Busslinger GA, Ponsioen B, Andersson-Rolf A, Saftien A, Boot C, Kretzschmar K, Geurts MH, Bar-Ephraim YE, Pleguezuelos-Manzano C, Post Y, Begthel H, van der Linden F, Lopez-Iglesias C, van de Wetering WJ, van der Linden R, Peters PJ, Heck AJR, Goedhart J, Snippert H, Zilbauer M, Teichmann SA, Wu W, Clevers H (2020) High-resolution mRNA and secretome atlas of human enteroendocrine cells. Cell 182:1062–1064. https://doi.org/10.1016/j.cell.2020.08.005 PubMed DOI

Bielle F, Freneaux P, Jeanne-Pasquier C, Maran-Gonzalez A, Rousseau A, Lamant L, Paris R, Pierron G, Nicolas AV, Sastre-Garau X, Delattre O, Bourdeaut F, Peuchmaur M (2012) PHOX2B immunolabeling: a novel tool for the diagnosis of undifferentiated neuroblastomas among childhood small round blue-cell tumors. Am J Surg Pathol 36:1141–1149. https://doi.org/10.1097/PAS.0b013e31825a6895 PubMed DOI

Borges M, Linnoila RI, van de Velde HJ, Chen H, Nelkin BD, Mabry M, Baylin SB, Ball DW (1997) An achaete-scute homologue essential for neuroendocrine differentiation in the lung. Nature 386:852–855. https://doi.org/10.1038/386852a0 PubMed DOI

Drabent P, Bonnard A, Guimiot F, Peuchmaur M, Berrebi D (2020) PHOX2B immunostaining: a simple and helpful tool for the recognition of ganglionic cells and diagnosis of Hirschsprung disease. Am J Surg Pathol 44:1389–1397. https://doi.org/10.1097/PAS.0000000000001528 PubMed DOI

Furlan A, Dyachuk V, Kastriti ME, Calvo-Enrique L, Abdo H, Hadjab S, Chontorotzea T, Akkuratova N, Usoskin D, Kamenev D, Petersen J, Sunadome K, Memic F, Marklund U, Fried K, Topilko P, Lallemend F, Kharchenko PV, Ernfors P, Adameyko I (2017) Multipotent peripheral glial cells generate neuroendocrine cells of the adrenal medulla. Science. https://doi.org/10.1126/science.aal3753

Gehart H, van Es JH, Hamer K, Beumer J, Kretzschmar K, Dekkers JF, Rios A, Clevers H (2019) Identification of enteroendocrine regulators by real-time single-cell differentiation mapping. Cell 176(1158–1173):e1116. https://doi.org/10.1016/j.cell.2018.12.029 DOI

Hata JL, Correa H, Krishnan C, Esbenshade AJ, Black JO, Chung DH, Mobley BC (2015) Diagnostic utility of PHOX2B in primary and treated neuroblastoma and in neuroblastoma metastatic to the bone marrow. Arch Pathol Lab Med 139:543–546. https://doi.org/10.5858/arpa.2014-0255-OA PubMed DOI

Huber K, Karch N, Ernsberger U, Goridis C, Unsicker K (2005) The role of Phox2B in chromaffin cell development. Dev Biol 279:501–508. https://doi.org/10.1016/j.ydbio.2005.01.007 PubMed DOI

Kimura N, Shiga K, Kaneko K, Sugisawa C, Katabami T, Naruse M (2020) The diagnostic dilemma of GATA3 immunohistochemistry in pheochromocytoma and paraganglioma. Endocr Pathol 31:95–100. https://doi.org/10.1007/s12022-020-09618-1 PubMed DOI

Lan MS, Breslin MB (2009) Structure, expression, and biological function of INSM1 transcription factor in neuroendocrine differentiation. FASEB J 23:2024–2033. https://doi.org/10.1096/fj.08-125971 PubMed DOI PMC

Lee JP, Hung YP, O′Dorisio TM, Howe JR, Hornick JL, Bellizzi AM (2017) Examination of PHOX2B in adult neuroendocrine neoplasms reveals relatively frequent expression in phaeochromocytomas and paragangliomas. Histopathology 71:503–510. https://doi.org/10.1111/his.13243 PubMed DOI PMC

Mamilla D, Manukyan I, Fetsch PA, Pacak K, Miettinen M (2020) Immunohistochemical distinction of paragangliomas from epithelial neuroendocrine tumors-gangliocytic duodenal and cauda equina paragangliomas align with epithelial neuroendocrine tumors. Hum Pathol 103:72–82. https://doi.org/10.1016/j.humpath.2020.07.010 PubMed DOI PMC

Mete O, Asa SL, Gill AJ, Kimura N, de Krijger RR (2022) Tischler A (2022) Overview of the WHO Classification of Paragangliomas and Pheochromocytomas. Endocr Pathol 33:90–114. https://doi.org/10.1007/s12022-022-09704-6 PubMed DOI

Mete O, Kefeli M, Caliskan S, Asa SL (2019) GATA3 immunoreactivity expands the transcription factor profile of pituitary neuroendocrine tumors. Mod Pathol 32:484–489. https://doi.org/10.1038/s41379-018-0167-7 PubMed DOI

Miettinen M, McCue PA, Sarlomo-Rikala M, Rys J, Czapiewski P, Wazny K, Langfort R, Waloszczyk P, Biernat W, Lasota J, Wang Z (2014) GATA3: a multispecific but potentially useful marker in surgical pathology: a systematic analysis of 2500 epithelial and nonepithelial tumors. Am J Surg Pathol 38:13–22. https://doi.org/10.1097/PAS.0b013e3182a0218f PubMed DOI PMC

Miyauchi M, Akashi T, Furukawa A, Uchida K, Tamura T, Ando N, Kirimura S, Shintaku H, Yamamoto K, Ito T, Miura K, Kayamori K, Ariizumi Y, Asakage T, Kudo A, Tanabe M, Fujii Y, Ishibashi H, Okubo K, Murakami M, Yamada T, Takemoto A, Bae Y, Eishi Y, Ohashi K (2022) PHOX2B is a sensitive and specific marker for the histopathological diagnosis of pheochromocytoma and paraganglioma. Endocr Pathol. https://doi.org/10.1007/s12022-022-09730-4

Nonaka D, Wang BY, Edmondson D, Beckett E, Sun CC (2013) A study of gata3 and phox2b expression in tumors of the autonomic nervous system. Am J Surg Pathol 37:1236–1241. https://doi.org/10.1097/PAS.0b013e318289c765 PubMed DOI

Ordonez NG (2014) Value of GATA3 immunostaining in the diagnosis of parathyroid tumors. Appl Immunohistochem Mol Morphol 22:756–761. https://doi.org/10.1097/PAI.0000000000000007 PubMed DOI

Simoes-Costa M, Bronner ME (2015) Establishing neural crest identity: a gene regulatory recipe. Development 142:242–257. https://doi.org/10.1242/dev.105445 PubMed DOI PMC

Soukup J, Manethova M, Kohout A, Soukup T, Dvorakova R, Drugda J, Vitovcova B, Gabalec F, Kaiser M, Kanta M, Kasparova P, Kozak J, Michnova L, Netuka D, Reguli S, Rychly B, Trnkova M, Vachata P, Wozniakova M, Cesak T (2022) Cauda equina neuroendocrine tumors show biological features distinct from other paragangliomas and visceral neuroendocrine tumors. Virchows Arch. https://doi.org/10.1007/s00428-022-03441-1

Uccella S, Facco C, Chiaravalli AM, Pettenon F, La Rosa S, Turri-Zanoni M, Castelnuovo P, Cerati M, Sessa F (2022) Transcription factor expression in sinonasal neuroendocrine neoplasms and olfactory neuroblastoma (ONB): Hyams’ grades 1–3 ONBs expand the spectrum of SATB2 and GATA3-positive neoplasms. Endocr Pathol 33:264–273. https://doi.org/10.1007/s12022-022-09715-3 PubMed DOI PMC

Unsicker K, Huber K, Schober A, Kalcheim C (2013) Resolved and open issues in chromaffin cell development. Mech Dev 130:324–329. https://doi.org/10.1016/j.mod.2012.11.004 PubMed DOI

Vermeiren S, Bellefroid EJ, Desiderio S (2020) Vertebrate sensory ganglia: common and divergent features of the transcriptional programs generating their functional specialization. Front Cell Dev Biol 8:587699. https://doi.org/10.3389/fcell.2020.587699 PubMed DOI PMC

Warren M, Matsuno R, Tran H, Shimada H (2018) Utility of Phox2b immunohistochemical stain in neural crest tumours and non-neural crest tumours in paediatric patients. Histopathology 72:685–696. https://doi.org/10.1111/his.13412 PubMed DOI

Wildner H, Gierl MS, Strehle M, Pla P, Birchmeier C (2008) Insm1 (IA-1) is a crucial component of the transcriptional network that controls differentiation of the sympatho-adrenal lineage. Development 135:473–481. https://doi.org/10.1242/dev.011783 PubMed DOI